Moreover, MEF2C expression seems to be BCBM-specific as almost no expression of this TF was observed when resected brain samples from glioma were analyzed as non-BCBM controls by focusing in regions with no reactive or neoplastic astrocytes and microglia to assure tissue integrity as much as possible. The gene discussed is TF; the disease is central nervous system cancer.